Literature DB >> 2372643

Recombinant human erythropoietin as adjuvant treatment for autologous blood donation.

H Graf1, U Watzinger, B Ludvik, A Wagner, P Höcker, K K Zweymüller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2372643      PMCID： PMC1663274          DOI： 10.1136/bmj.300.6740.1627

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Prior deposition of autologous blood in elective orthopaedic surgery.

Authors:  J D Thomson; J J Callaghan; C G Savory; R P Stanton; R N Pierce
Journal:  J Bone Joint Surg Am       Date:  1987-03       Impact factor: 5.284

2.  Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy.

Authors:  L T Goodnough; S Rudnick; T H Price; S K Ballas; M L Collins; J P Crowley; M Kosmin; M S Kruskall; B A Lenes; J E Menitove
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245
  2 in total
  2 in total

Review 1.  [Possibilities for avoiding homologous blood transfusion in surgical interventions].

Authors:  G Klein
Journal:  Unfallchirurgie       Date:  1992-10

2.  Regional transfusion centre preoperative autologous blood donation programme: the first two years.

Authors:  M R Howard; C E Chapman; J A Dunstan; C Mitchell; H L Lloyd
Journal:  BMJ       Date:  1992-12-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.